首页> 外文OA文献 >Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression
【2h】

Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression

机译:社会经济因素解释了在艾滋病毒感染的澳大利亚成年人中对抗逆转录病毒疗法的依从性不佳

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

© 2017 Siefried et al.This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Background Missing more than one tablet of contemporary antiretroviral therapy (ART) per month increases the risk of virological failure. Recent studies evaluating a comprehensive range of potential risk factors for suboptimal adherence are not available for high-income settings. Methods Adults on ART with undetectable viral load (UDVL) were recruited into a national, multicentre cohort, completing a comprehensive survey assessing demographics, socioeconomic indicators, physical health, well-being, life stressors, social supports, HIV disclosure, HIV-related stigma and discrimination, healthcare access, ART regimen, adherence, side effects, costs and treatment beliefs. Baseline data were assessed, and suboptimal adherence was defined as self-reported missing 1 ART dose/month over the previous 3- months; associated factors were identified using bivariate and multivariate binary logistic regression. Results We assessed 522 participants (494 [94.5%] men, mean age = 50.8 years, median duration UDVL = 3.3 years [IQR = 1.2±6.8] ) at 17 sexual health, hospital, and general practice clinics across Australia. Seventy-eight participants (14.9%) reported missing 1 dose/month over the previous three months, which was independently associated with: being Australian-born (AOR [adjusted odds ratio] = 2.4 [95%CI = 1.2±4.9] , p = 0.014), not being in a relationship (AOR = 3.3 [95%CI = 1.5±7.3], p = 0.004), reaching the 'Medicare safety net' (capping annual medical/pharmaceutical costs) (AOR = 2.2 [95%CI = 1.1±4.5] , p = 0.024), living in subsidised housing (AOR = 2.5 [95%CI = 1.0±6.2], p = 0.045), receiving home-care services (AOR = 4.4 [95%CI = 1.0±18.8] , p = 0.046), HIV community/outreach services linkage (AOR = 2.4 [95%CI = 1.1±5.4], p = 0.033), and starting ART following self-request (AOR = 3.0 [95%CI = 1.3±7.0] , p = 0.012). Conclusions In this population, 15% reported recent suboptimal ART adherence at levels associated in prospective studies with subsequent virological failure, despite all having an undetectable viral load. Associations were with social/economic/cultural/patient engagement factors, but not ART regimen/clinical factors. These associations may help identify those at higher risk of future virological failure and guide patient education and support.
机译:©2017 Siefried等人,这是根据知识共享署名许可协议的条款分发的开放获取文章,该文章允许在任何媒介中不受限制地使用,分发和复制,但要注明原始作者和出处。背景技术每月错过一片以上的现代抗逆转录病毒疗法(ART)会增加病毒学失败的风险。对于高收入人群,最近的研究评估了次最佳依从性的潜在风险因素的综合范围,目前尚无法获得。方法将具有不可检测的病毒载量(UDVL)的ART成人纳入一个全国性的多中心队列,完成一项全面的调查,评估人口统计学,社会经济指标,身体健康,福祉,生活压力,社会支持,HIV感染,与艾滋病相关的污名歧视,医疗保健,ART方案,依从性,副作用,费用和治疗信念。评估基线数据,将次佳依从性定义为在过去3个月中自我报告的每月缺少1个ART剂量;使用二元和多元二元逻辑回归分析确定相关因素。结果我们评估了澳大利亚17家性健康诊所,医院和普通诊所的522名参与者(494名[94.5%]男性,平均年龄= 50.8岁,中位持续时间UDVL = 3.3年[IQR = 1.2±6.8])。七十八名参与者(14.9%)报告说,过去三个月每月缺少1剂药物,其与以下因素独立相关:生于澳大利亚(AOR [调整后的优势比] = 2.4 [95%CI = 1.2±4.9],p = 0.014),没有关系(AOR = 3.3 [95%CI = 1.5±7.3],p = 0.004),达到了“医疗保险安全网”(最高年度医疗/药品成本)(AOR = 2.2 [95% CI = 1.1±4.5],p = 0.024),住在有补贴的住房中(AOR = 2.5 [95%CI = 1.0±6.2],p = 0.045),接受家庭护理服务(AOR = 4.4 [95%CI = 1.0] ±18.8],p = 0.046),艾滋病病毒社区/外展服务联系(AOR = 2.4 [95%CI = 1.1±5.4],p = 0.033),并在自我要求后开始抗病毒治疗(AOR = 3.0 [95%CI = 1.3±7.0],p = 0.012)。结论在该人群中,尽管所有人群均具有无法检测到的病毒载量,但仍有15%的人报告其前瞻性研究中近期亚最佳ART依从性与随后的病毒学失败相关。与社会/经济/文化/患者参与因素有关,而与ART方案/临床因素无关。这些协会可以帮助确定那些未来病毒学失败风险较高的人,并指导患者的教育和支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号